116 related articles for article (PubMed ID: 18198639)
1. [Effect of tetramethylpyrazine on platelet activation and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1078-81. PubMed ID: 18198639
[TBL] [Abstract][Full Text] [Related]
2. [Effect of tongxinluo capsule on platelet activities and vascular endothelial functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):487-91. PubMed ID: 21608219
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
Chen ZQ; Hong L; Wang H; Yin QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611
[TBL] [Abstract][Full Text] [Related]
4. [Effect of danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):692-4. PubMed ID: 19848198
[TBL] [Abstract][Full Text] [Related]
5. [Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Zhao PX; Jiang S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):11-4. PubMed ID: 21434335
[TBL] [Abstract][Full Text] [Related]
6. [Effect of tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris].
Wang HJ; Huang YW; Sun J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):587-9. PubMed ID: 14503056
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of fuzheng jiangnian capsule in improving pre-thrombosis correlated factors in patients with coronary heart disease].
Li LY; Ren GH; Liu XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):691-5. PubMed ID: 16152823
[TBL] [Abstract][Full Text] [Related]
8. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Tongxinluo on endothelial function and hypersensitive C-reactive protein in acute coronary syndrome patients undergoing percutaneous coronary intervention].
Ma Q; Zhang S; Ning Y; Pu X; Yu G; Zheng Z; Chen X; Hu K; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):550-4. PubMed ID: 19587440
[TBL] [Abstract][Full Text] [Related]
10. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
11. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
Gurbel PA; Erlinge D; Ohman EM; Neely B; Neely M; Goodman SG; Huber K; Chan MY; Cornel JH; Brown E; Zhou C; Jakubowski JA; White HD; Fox KA; Prabhakaran D; Armstrong PW; Tantry US; Roe MT;
JAMA; 2012 Nov; 308(17):1785-94. PubMed ID: 23117779
[TBL] [Abstract][Full Text] [Related]
12. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD;
JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194
[TBL] [Abstract][Full Text] [Related]
13. [Effects of tongxinluo capsule on platelet activating and inflammation factors as well as vascular endothelial function in patients with essential hypertension complicated with diabetes mellitus].
Zhang CQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):376-9. PubMed ID: 20669673
[TBL] [Abstract][Full Text] [Related]
14. [Effect of naoxintong capsule on the vascular endothelial function and the infarct size of patients with acute myocardial infarction].
Li LX; Chen L; Zhao HJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1615-8. PubMed ID: 22384546
[TBL] [Abstract][Full Text] [Related]
15. [Study on relationship of clinical effect of xuefu zhuyu concentrated pill and serum pharmacological anti-platelet activating effect in vitro].
Lei Y; Chen KJ; Li ZW
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Apr; 22(4):270-3. PubMed ID: 12584788
[TBL] [Abstract][Full Text] [Related]
16. [Effect of danshen chuanxiongqin injection on the myocardial damage of unstable angina patients undergoing percutaneous coronary intervention].
Wang R; Han QH; Jia YP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):899-902. PubMed ID: 21866658
[TBL] [Abstract][Full Text] [Related]
17. Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
De Servi S; Mariani M; Vandoni P; Dellavalle A; Politi A; Poletti F; Bonizzoni E; Leoncinie M;
J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):159-65. PubMed ID: 16645379
[TBL] [Abstract][Full Text] [Related]
18. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
[TBL] [Abstract][Full Text] [Related]
20. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
